<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05014880</url>
  </required_header>
  <id_info>
    <org_study_id>200530</org_study_id>
    <nct_id>NCT05014880</nct_id>
  </id_info>
  <brief_title>Impact of Time Restricted Eating on Patients With Coronary Artery Disease (CAD) Undergoing Cardiac Rehabilitation</brief_title>
  <acronym>TRE x ICR</acronym>
  <official_title>Impact of Time Restricted Eating on Exercise Capacity, Cardiometabolic Parameters, and Trimethylamine N-oxide (TMAO) Levels in Patients With Coronary Artery Disease (CAD) Undergoing Cardiac Rehabilitation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Diego</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Salk Institute for Biological Studies</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, San Diego</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to see if reducing the number of hours during which one eats&#xD;
      each day will help reduce levels of LDL cholesterol and improve other markers of metabolic&#xD;
      and cardiovascular health (i.e. blood sugar levels and blood pressure). The study also aims&#xD;
      to assess changes in exercise capacity and trimethylamine N-oxide (TMAO) levels in response&#xD;
      to Time Restricted Eating (TRE) and Intensive Cardiac Rehabilitation (ICR) versus ICR alone.&#xD;
      TMAO is a metabolite, or a substance, produced during digestion and metabolism. Preliminary&#xD;
      data illustrates a correlation between high levels of TMAO and higher risk of cardiovascular&#xD;
      disease and mortality. We will also be looking at participants' long-term cardiovascular&#xD;
      health status after they complete the ICR program.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 2, 2021</start_date>
  <completion_date type="Anticipated">March 2, 2023</completion_date>
  <primary_completion_date type="Anticipated">March 2, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Exercise Capacity (MetS)</measure>
    <time_frame>Baseline and Week 1-9</time_frame>
    <description>Exercise Capacity</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in LDL cholesterol</measure>
    <time_frame>Baseline and Week 9</time_frame>
    <description>LDL cholesterol (mg/dL)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in non-HDL cholesterol</measure>
    <time_frame>Baseline and Week 9</time_frame>
    <description>non-HDL cholesterol (mg/dL)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Triglycerides</measure>
    <time_frame>Baseline and Week 9</time_frame>
    <description>Triglycerides (mg/dL)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Change in TMAO levels</measure>
    <time_frame>Baseline and Week 9</time_frame>
    <description>TMAO levels (uM)</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>ICR (Intensive Cardiac Rehabilitation)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>20 patients will be randomly assigned to the standard of care group, which will receive the standard health and nutritional wellness guidelines that are required of UCSD's 9-week ICR program, referred to as the &quot;ICR&quot; group.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ICR x TRE (Intensive Cardiac Rehabilitation x Time-Restricted Eating)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>20 patients will be randomly assigned to the Time-Restricted Eating (TRE) group which will be asked to limit the number of hours they eat in a day to 10 hours in addition to receiving the standard of care health and nutritional wellness guidelines that are required of UCSD's 9-week ICR program, referred to as the &quot;ICR x TRE&quot; group.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>ICR (Intensive Cardiac Rehabilitation)</intervention_name>
    <description>Participants in this arm will not have to adopt a 10-hour eating window while taking part in UCSD's 9-week ICR program.</description>
    <arm_group_label>ICR (Intensive Cardiac Rehabilitation)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>ICR x TRE (Intensive Cardiac Rehabilitation x Time-Restricted Eating)</intervention_name>
    <description>Participants in this arm will adhere to a daily, consistent 10-hour eating window while undergoing UCSD's 9-week ICR program to see if there is an improvement on cardiometabolic parameters.</description>
    <arm_group_label>ICR x TRE (Intensive Cardiac Rehabilitation x Time-Restricted Eating)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age: 18-75 years&#xD;
&#xD;
          2. Enrollment and planned participation in UC San Diego's 9-week Intensive Cardiac&#xD;
             Rehabilitation Program&#xD;
&#xD;
          3. Established diagnosis of coronary artery disease (concomitant systolic or diastolic HF&#xD;
             is allowable)&#xD;
&#xD;
          4. Own a smartphone (Apple iOS or Android OS)&#xD;
&#xD;
          5. If patients are on cardiovascular medications (HMG CoA reductase inhibitors (statins),&#xD;
             other lipid modifying drugs (including over the counter drugs such as red yeast rice&#xD;
             and fish oil), anti-hypertensive, anti-diabetes drugs, no dose adjustments will be&#xD;
             allowed during the study period.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Taking insulin within the last 6 months.&#xD;
&#xD;
          2. Known inflammatory and/or rheumatologic disease.&#xD;
&#xD;
          3. Active tobacco abuse or illicit drug use or history of treatment for alcohol abuse.&#xD;
&#xD;
          4. Pregnant or breast-feeding women.&#xD;
&#xD;
          5. Shift workers with variable (e.g. nocturnal) hours.&#xD;
&#xD;
          6. Caregivers for dependents requiring frequent nocturnal care/sleep interruptions.&#xD;
&#xD;
          7. Planned international travel during study period.&#xD;
&#xD;
          8. Systolic HF alone.&#xD;
&#xD;
          9. Heart transplant within the past 1 year.&#xD;
&#xD;
         10. Presence of left ventricular assist device.&#xD;
&#xD;
         11. Uncontrolled arrhythmia (i.e. rate-controlled atrial fibrillation/atrial flutter are&#xD;
             not exclusion criteria).&#xD;
&#xD;
         12. History of thyroid disease requiring dose titration of thyroid replacement&#xD;
             medication(s) within the past 3 months (i.e. hypothyroidism on a stable dose of&#xD;
             thyroid replacement therapy is not an exclusion).&#xD;
&#xD;
         13. History of adrenal disease.&#xD;
&#xD;
         14. History of malignancy undergoing active treatment, except non-melanoma skin cancer.&#xD;
&#xD;
         15. History of type I diabetes with ongoing insulin dependence.&#xD;
&#xD;
         16. History of eating disorders.&#xD;
&#xD;
         17. History of cirrhosis.&#xD;
&#xD;
         18. History of stage 4 or 5 chronic kidney disease or requiring dialysis.&#xD;
&#xD;
         19. History of HIV/AIDS.&#xD;
&#xD;
         20. Currently enrolled in a weight-loss or weight-management program. This does not&#xD;
             include UC San Diego's Cardiac Rehabilitation Programs.&#xD;
&#xD;
         21. On a special or prescribed diet for other reasons (e.g. Celiac disease).&#xD;
&#xD;
         22. Currently taking any medication that is meant for, or has a known effect on, appetite.&#xD;
&#xD;
         23. Any history of surgical intervention for weight management.&#xD;
&#xD;
         24. Uncontrolled psychiatric disorder (including history of hospitalization for&#xD;
             psychiatric illness).&#xD;
&#xD;
         25. Baseline eating window &lt;14 hours per day as documented on mCC app.&#xD;
&#xD;
         26. Failure to use the smartphone app for documentation (defined as &lt;2 meals/day for â‰¥3&#xD;
             days during baseline).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pam R Taub, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UC San Diego Health</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>David T Van, BS</last_name>
    <phone>858-246-2342</phone>
    <email>ucsdresearchcoordinator@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Victoria A Green, BS</last_name>
    <phone>858-246-2406</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Altman Clinical and Translational Research Institute</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92093</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David T Van, BS</last_name>
      <phone>858-246-2342</phone>
      <email>ucsdresearchcoordinator@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Victoria A Green, BS</last_name>
      <phone>858-246-2406</phone>
    </contact_backup>
    <investigator>
      <last_name>Pam R Taub, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>August 13, 2021</study_first_submitted>
  <study_first_submitted_qc>August 13, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 20, 2021</study_first_posted>
  <last_update_submitted>September 2, 2021</last_update_submitted>
  <last_update_submitted_qc>September 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, San Diego</investigator_affiliation>
    <investigator_full_name>Pam Taub, MD</investigator_full_name>
    <investigator_title>Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>Time Restricted Eating</keyword>
  <keyword>Circadian Rhythm</keyword>
  <keyword>Cardiac Rehabilitation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

